11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Evaluation of Binax NOW RSV as an acute point-of-care screening test in a paediatric accident and emergency unit.

      Communicable disease and public health / PHLS
      Cross Infection, prevention & control, Emergency Service, Hospital, Female, Fluorescent Antibody Technique, Humans, Infant, Male, Mass Screening, methods, Point-of-Care Systems, Prospective Studies, Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus, Human, isolation & purification, Sensitivity and Specificity

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Point-of-care tests (POCTs) for respiratory syncytial virus infections are a useful adjunct to reduce the risk of healthcare-associated infections in paediatric wards. A new test based on immunochromatography, Binax NOW RSV, was introduced in the winter of 2002-03. It has user friendly features making it particularly suitable for non-laboratory personnel in a paediatric accident and emergency unit. A prospective study comparing the POCT with laboratory-based direct immunofluorescence (DIF) showed sensitivity of 87% specificity of 94%, positive predictive value of 89% and negative predictive value 92%. The simplicity of Binax NOW RSV should not detract from training staff and maintaining consistent vigilance on quality control.

          Related collections

          Author and article information

          Comments

          Comment on this article